ISRCTN15314870已完成不适用
evamisole hydrochloride as adjunctive therapy in falciparum malaria
niversity of Oxford (UK)0 个研究点目标入组 40 人开始时间: 2005年10月14日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. The patient or attending relative is able and willing to give informed consent - the proposed consent form and information sheets are attached and will be translated into Burmese
- •2. Uncomplicated falciparum malaria
- •3. Patients aged 16 to 65 years old, either sex
- •4. No contraindications to levamisole, quinine or doxycycline therapy, like documented allergies to any of the drugs
排除标准
- •1. Patient or relatives unable or unwilling to give informed consent
- •2. Previous antimalarial treatment within one week of admission
- •3. Pregnancy
研究者
相似试验
已完成
不适用
evamisole hydrochloride as adjunctive therapy in severe falciparum malaria with high parasitaemiaSevere falciparum malaria with high parasitaemiaInfections and InfestationsMalariaISRCTN27232551niversity of Oxford (United Kingdom)60
已完成
3 期
Efficacy of Levamisol in Treating COVID-19IRCT20201124049480N1Artesh University of Medical Sciences365
尚未招募
3 期
Effect of Empagliflozin as adjunctive therapy versus placebo on serum level of oxidative stress biomarkers in diabetic patients with systolic heart failureIRCT20120215009014N484Hamedan University of Medical Sciences80
招募中
3 期
Prevention of the return of nephrotic syndrom in children by adding levamisole to prednisolone treatment2024-517467-23-00Amsterdam UMC Stichting87
进行中（未招募）
1 期
Prevention of the return of nephrotic syndrom in children by adding levamisole to prednisolone treatmentEUCTR2017-001025-41-BEAmsterdam University Medical Center, location AMC92